1 / 9

Antidiabetics Market share to grow at 10.5% CAGR from 2016 to 2024

Get more details @ http://bit.ly/2t2aMfX <br>Some of the major players dominating global antidiabetics market are Novo Nordisk, Eli Lilly and Sanofi. Extensive product portfolio and rising R&D investment for producing innovative and pipeline products are the major strategies adopted by these players to maintain their market share.

jueekate
Download Presentation

Antidiabetics Market share to grow at 10.5% CAGR from 2016 to 2024

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Antidiabetics Market to surpass $110Bn by 2024: Global Market Insights Inc.

  2. Key Insights from Antidiabetics Market : • Inherently propelled by a stringent regulatory framework, antidiabetics market is strongly characterized by the legalized norms implemented by authorized bodies such as the European CE and the FDA. • Having undertaken the crucial responsibility of regulating the commercialization of antidiabetics in clinical trials, these organizations continue to strive hard to approve drugs post their testing with utmost caution and precision, which is a prime factor driving the growth of antidiabetics industry. • Apparently, this drug is an all-new formulation of Bydureon that is available as a single-dose autoinjector device for adults suffering from Type II diabetes. • The BydureonBCise apparently underwent two clinical trials prior to obtaining the approval, thus validating the fact that antidiabetics market outlook is strictly defined by a regulatory frame of reference. • The program will also make people aware of the harmful consequences of developing diabetes, encourage them to get screened regularly, and provide other related details.

  3. Continued... • The prevalence of campaigns and awareness programs such as the aforementioned are certain to bring about a positive influence on antidiabetics market size, which was pegged at USD 49.5 billion in 2016. • Major companies such as Sanofi Aventis, Eli Lilly, and Novo Nordisk presently predominate antidiabetic market share, pertaining to their popular brand value, wide range of products, and increased R&D investments. • In addition, global antidiabetics industry involves the participation of other generic manufacturers such as Pfizer, Oramed Pharmaceuticals, Inc., Takeda Pharmaceuticals, Boehringer Ingelheim, and Merck & Co. Inc. • This estimation may be attributed to the fact that the region has been witnessing a tremendous surge in the patient pool suffering from diabetes, especially in India and China. • With a strong regulatory framework and governmental support in place, not to mention, the pivotal developments underlining the medical research and healthcare verticals, it is forecast that antidiabetics industry will chart a profitable growth curve over the coming seven years, with an estimated valuation of USD 110 billion by 2024.

  4. India Antidiabetics Market, By Product, 2013 - 2024 (USD Million)

  5. Table of Content: Chapter 1. Methodology 1.1. Methodology 1.1.1. Initial data exploration 1.1.2. Statistical modeling and forecast 1.1.3. Industry insights and validation 1.1.4. Market definition and forecast parameters 1.2. Data sources 1.2.1. Secondary 1.2.2. Primary Chapter 2.Executive Summary 2.1. Antidiabetics industry 3600 synopsis, 2013 - 2024 2.1.1. Business trends 2.1.2. Product trends 2.1.3. Application trends 2.1.4. Regional trends

  6. Table of Content: Chapter 3. Antidiabetics Industry Insights 3.1. Industry segmentation 3.2. Industry landscape, 2013 – 2024 3.3. Industry impact forces 3.3.1. Growth drivers 3.3.1.1. Gradual increase in prevalence of diabetes 3.3.1.2. Presence of strong product pipeline portfolio 3.3.1.3. Increasing prevalence of lifestyle induced disorders such as obesity 3.3.2. Industry pitfalls & challenges 3.3.2.1. High insulin prices 3.4. Growth potential analysis 3.4.1. By product 3.4.2. By application 3.5. Regulatory landscape 3.5.1. U.S 3.5.2. Europe

  7. Table of Content: 3.6. Reimbursement scenario 3.6.1. U.S 3.6.2. Europe 3.7. Pipeline overview 3.8. Porter’s analysis 3.9. Competitive landscape, 2016 3.9.1. Business overview 3.9.2. Revenue analysis 3.9.3. Product landscape 3.9.4. Strategy dashboard 3.10. PESTEL analysis

  8. Browse Full Market Research Report On Antidiabetics Market @ http://bit.ly/2zArLIV Request for a Sample of this Research Report @ https://www.gminsights.com/request-sample/detail/504https://www.gminsights.com/request-sample/detail/49

  9. Stay In Touch Website: www.gminsights.com Social Media:

More Related